In numerous animal models, MCC950 has been shown to reduce IL-1β and IL-18 levels in the hippocampus and amygdala, decrease microgliosis, and reverse anhedonia, depressive, and anxiety-like behaviors [63,64]. This evidence concerns the gene IL1B and Anxiety.